Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-034191
Filing Date
2022-12-01
Accepted
2022-12-01 17:00:38
Documents
2
Period of Report
2022-11-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3102
2 ex24.htm EX-24 10604
  Complete submission text file 0001493152-22-034191.txt   15009
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CINGULATE INC. 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address
Myers Laurie (Reporting) CIK: 0001883920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40874 | Film No.: 221439445